Nitrocard (Glyceryl Trinitrate)

Glyceryl Trinitrate, the active ingredient in Nitrocard, is an organic nitrate vasodilator presented as a transdermal patch for cutaneous use. It is employed to relieve acute angina pectoris, prevent angina episodes, and manage certain cases of heart failure in adult patients.

GNH USA supplies Nitrocard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to European Union pharmacopeial standards and is manufactured under GMP conditions, ensuring consistent potency and safety for global distribution.

Nitrocard (glyceryl trinitrate) is used in the cardiovascular disease category to alleviate ischemic chest pain and improve cardiac function.

- Acute angina pectoris: rapid relief of chest pain by vasodilation of coronary arteries. - Prophylaxis of angina pectoris: prevention of angina attacks during exertion or emotional stress. - Heart failure: reduction of preload and afterload to improve symptoms in selected patients.

Transdermal glyceryl trinitrate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: throbbing pain often triggered by vasodilation. - Flushing: warmth and redness of the skin. - Dizziness or light‑headedness due to lowered blood pressure. - Hypotension: measurable drop in systolic/diastolic pressure. - Tachycardia: compensatory increase in heart rate. - Skin irritation at the patch site.

Serious or Rare Side Effects: - Severe hypotension leading to syncope. - Myocardial infarction in susceptible individuals. - Methemoglobinemia causing reduced oxygen delivery. - Allergic skin reaction or severe rash. - Refractory angina unresponsive to therapy. - Life‑threatening arrhythmias (rare).

When prescribing Nitrocard, clinicians should observe several precautionary measures to minimize risk.

- Concomitant PDE5 inhibitors: avoid use due to risk of profound hypotension. - Other nitrates or nitric‑oxide donors: avoid combined therapy to prevent excessive vasodilation. - Blood pressure monitoring: check baseline and periodic BP to detect hypotension. - Abrupt discontinuation: taper off to reduce rebound angina. - Heat exposure: keep patch away from external heat sources to prevent increased drug release. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Nitrocard can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): may cause severe hypotension. - Other nitrates (e.g., isosorbide dinitrate): additive vasodilatory effect leading to dangerous blood‑pressure drops. - Guanylate cyclase stimulators (e.g., riociguat): risk of excessive vasodilation. - High‑dose antihypertensives (e.g., ACE inhibitors) when combined may precipitate profound hypotension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia but increase risk of bradycardia. - Calcium‑channel blockers: additive blood‑pressure lowering effect. - Diuretics: may enhance volume depletion and hypotension. - ACE inhibitors/ARBs: monitor for synergistic BP reduction. - Alcohol: excessive intake can augment hypotensive response.